Wednesday, September 21, 2016 5:23:18 PM
Sure, things can go faster, but that is based on factors that are both within and outside of company control. The big one that everyone thinks is 100% in CTIX control is money. I argue that is only partially true. CTIX has demonstrated that they have been able to manage their funds well when it has been in their control. The part out of their control is share price and new investment. The company has/is relying upon share price to execute funding agreements so a result of the targeted takedown, by way of an fallacious article and lawsuits, tanked the value and therefore stalled and increased durations to accomplish the trials. I argue that this type of delay was/is out of the company control, because they are not going to take drastic measures which will hurt the company long term, just to get a potential boost short term. So with less value available in the share price management then focused on how to adjust plans to maximize the speed of progress with pushing forward on the drug(s) which will have the greatest chance of securing that necessary funding through a buyout or partnership. This is where we are at now.
Long story short is, I believe that CTIX has made the best of the circumstances which they have been faced with. They have continued to make actual, meaningful, company progress to bring drugs closer to the point of generating real value in the share price, all the while doing within industry standard timetables. So keep the faith, so to speak, because as soon as a deal is signed for P CTIX will have the funds necessary to accelerate the remainder of the pipeline and us share holders will get those coveted gains we have been patiently waiting for.
https://pbs.twimg.com/media/CselIwzWAAE0AaN.jpg:large
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM